JERSEY CITY, N.J., Feb. 3, 2022 /PRNewswire/ The newly published report titled "Global Cannabinoid Derived Pharmaceutical Market - By Trends, Industry Competition Analysis, Pipeline Analysis
We reviewed data on the American diet from 1800 to 2019. Methods We examined food availability and estimated consumption data from 1808-2019 using historical sources from the federal government and additional public data sources. Results Processed and ultra-processed foods increased from 60% of foods. Large increases occurred for sugar, white and whole wheat flour, rice, poultry, eggs, and vegetable oils, dairy products, and fresh vegetables. Saturated fats from animal sources declined while polyunsaturated fats from vegetable oils rose. Noncommunicable diseases (NCDs) rose over the 20th century in parallel with increased consumption of processed foods, including sugar, refined flour and rice, and vegetable oils. Saturated fats from animal sources were inversely correlated with the prevalence of NCDs. Conclusions As observed from the food availability data, processed and ultra-processed foods dramatically increased over the past two centuries, especially sugar, white flour, white rice,
Quantification may help stratify SUDEP risk People who died due to sudden unexpected death in epilepsy (SUDEP) had changes in frequency-domain measures of heart rate variability compared with living epilepsy controls, a retrospective, nested case-control study found. Compared with non-SUDEP epilepsy controls, epilepsy patients who died with SUDEP had lower normalized awake low-frequency power (LFP)
Operator
Good afternoon, and welcome to MannKind Corporation first-quarter 2021 earnings call. As a reminder this call is being recorded on May 12th, 2021, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until May 26, 2021. This call will contain forward-looking statements. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from these stated expectations.
For further information on the company s risk factors please see their 10-Q report filed with the Securities and Exchange Commission this morning, the earnings release and the slides prepared for this presentation. Joining us today from Mannkind are Chief Executive Officer Michael Castagna, and Chief Financial Officer Steven Binder. I would now like to turn the conference over to Mr. Castagna.